General
Oxford University to launch trial alternating coronavirus vaccines from AstraZeneca and Pfizer-BioNTech
Oxford University says it will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
Key points:
- The trial aims to determine whether different COVID-19 doses can be used interchangeably
- If successful, it could lead to a more flexible vaccine rollout, says the UK’s chief health officer
- Britain has been administering vaccines at an interval of 12 weeks to give more people a first dose, unlike other countries
The trial aims to determine whether different COVID-19 vaccine doses — those created by the AstraZeneca and Pfizer-BioNTech pharmaceutical companies — can be used interchangeably.
If successful it could allow greater flexibility in pressured vaccine delivery schedules.
The UK’s Deputy Chief Medical…
-
Business19 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Noosa News15 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News15 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business18 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025